Akcea Therapeutics Competitors and Similar CompaniesClear all
Akcea Therapeutics's competitors and similar companies include Biogen, Cadila Pharmaceuticals and Alembic Pharmaceuticals.
 Akcea Therapeutics Akcea Therapeutics is a late-stage biopharmaceutical company developing drugs for the treatment of cardiometabolic diseases caused by lipid disorders. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates | |
Founding Date | Founding Date 2014 | Founding Date 1978 | Founding Date 1951 | Founding Date 2010 |
Type | Type Subsidiary | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Boston, US HQ Cambridge, US | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN | |
Employees | Employees 100 | Employees 7,605 | Employees 8,5201% increase | Employees 14,858 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹73.4b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A | Cost of goods ₹19.8b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit $7.5b (FY, 2025) | Gross profit N/A | Gross profit ₹54.1b (FY, 2026) |
Net income | Net income N/A | Net income $1.3b (FY, 2025) | Net income N/A | Net income ₹6.7b (FY, 2026) |
Operating ⚠ | ||||
Phase I Trials Products | Phase I Trials Products 2 (Jun, 2017) | Phase I Trials Products 4 (FY, 2024) | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase I/II Trials Products | Phase I/II Trials Products 1 (Jun, 2017) | Phase I/II Trials Products 1 (FY, 2022) | Phase I/II Trials Products N/A | Phase I/II Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 1 (Jun, 2017) | Phase II Trials Products 6 (FY, 2024) | Phase II Trials Products N/A | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products 1 (Jun, 2017) | Phase III Trials Products 11 (FY, 2024) | Phase III Trials Products N/A | Phase III Trials Products N/A |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyCadila Pharmaceuticals
HQ
Bavla, IN
Employees
8,520↑ 1% increase
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View companyAlembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View company